28
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Recent trends in life expectancy across high income countries: retrospective observational study

      research-article
      1 , , 2
      The BMJ
      BMJ Publishing Group Ltd.

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objectives

          To assess whether declines in life expectancy occurred across high income countries during 2014-16, to identify the causes of death contributing to these declines, and to examine the extent to which these declines were driven by shared or differing factors across countries.

          Design

          Demographic analysis using aggregated data.

          Setting

          Vital statistics systems of 18 member countries of the Organisation for Economic Co-operation and Development.

          Participants

          18 countries with high quality all cause and cause specific mortality data available in 2014-16.

          Main outcome measures

          Life expectancy at birth, 0-65 years, and 65 or more years and cause of death contributions to changes in life expectancy at birth.

          Results

          The majority of high income countries in the study experienced declines in life expectancy during 2014-15; of the 18 countries, 12 experienced declines in life expectancy among women and 11 experienced declines in life expectancy among men. The average decline was 0.21 years for women and 0.18 years for men. In most countries experiencing declines in life expectancy, these declines were predominantly driven by trends in older age (≥65 years) mortality and in deaths related to respiratory disease, cardiovascular disease, nervous system disease, and mental disorders. In the United States, declines in life expectancy were more concentrated at younger ages (0-65 years), and drug overdose and other external causes of death played important roles in driving these declines.

          Conclusions

          Most of the countries that experienced declines in life expectancy during 2014-15 experienced robust gains in life expectancy during 2015-16 that more than compensated for the declines. However, the United Kingdom and the United States appear to be experiencing stagnating or continued declines in life expectancy, raising questions about future trends in these countries.

          Related collections

          Most cited references27

          • Record: found
          • Abstract: found
          • Article: not found

          Changes in Synthetic Opioid Involvement in Drug Overdose Deaths in the United States, 2010-2016

          This study uses National Vital Statistics System data to describe trends in synthetic opioid involvement in drug overdose deaths in the United States from 2010 to 2016.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Twenty-five years of prescription opioid use in Australia: a whole-of-population analysis using pharmaceutical claims

            Aim The aim of this paper is to investigate 25‐year trends in community use of prescribed opioid analgesics in Australia, and to map these trends against major changes to opioid registration and subsidy. Methods We obtained dispensing data from 1990 to 2014 from two sources: dispensing claims processed under Australia's national drug subsidy programme, the Pharmaceutical Benefits Scheme, including under co‐payment records from 2012; and estimates of non‐subsidized medicine use from a survey of Australian pharmacies (until 2011). Utilization was expressed in defined daily doses (DDD)/1000 population/day. Results Opioid dispensing increased almost four‐fold between 1990 and 2014, from 4.6 to 17.4 DDD/1000 pop/day. In 1990, weak, short‐acting or orally administered opioids accounted for over 90% of utilization. Use of long‐acting opioids increased over 17‐fold between 1990 and 2000, due primarily to the subsidy of long‐acting morphine and increased use of methadone for pain management. Between 2000 and 2011, oxycodone, fentanyl, buprenorphine, tramadol and hydromorphone use increased markedly. Use of strong opioids, long‐acting and transdermal preparations also increased, largely following the subsidy of various opioids for noncancer pain. In 2011, the most dispensed opioids were codeine (41.1% of total opioid use), oxycodone (19.7%) and tramadol (16.1%); long‐acting formulations comprised approximately half, and strong opioids 40%, of opioid dispensing. Conclusions Opioid utilization in Australia is increasing, although these figures remain below levels reported in the US and Canada. The increased use of opioids was largely driven by the subsidy of long‐acting formulations and opioids for the treatment of noncancer pain.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              A nonidentifiability aspect of the problem of competing risks.

              A. Tsiatis (1975)
                Bookmark

                Author and article information

                Contributors
                Role: assistant professor
                Role: assistant professor
                Journal
                BMJ
                BMJ
                BMJ-US
                bmj
                The BMJ
                BMJ Publishing Group Ltd.
                0959-8138
                1756-1833
                2018
                15 August 2018
                : 362
                : k2562
                Affiliations
                [1 ]Leonard Davis School of Gerontology and Department of Sociology, University of Southern California, 3715 McClintock Avenue, Los Angeles, CA 90089, USA
                [2 ]Office of Population Research and Department of Sociology, Princeton University, Princeton, NJ, USA
                Author notes
                Correspondence to: JY Ho jessicyh@ 123456usc.edu
                Article
                hoj043740
                10.1136/bmj.k2562
                6092679
                30111634
                ea6e9d87-73a3-44cf-93d4-5732c3d66e8d
                Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions

                This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

                History
                : 04 June 2018
                Categories
                Research

                Medicine
                Medicine

                Comments

                Comment on this article